Current and future prospects for xenotransplantation

Reproduction, Fertility and Development

Volumn 10, Issue 7-8, 1998, Pages 683-696

  French, Andrew J ^a   Greenstein, Julia L ^b   Loveland, Bruce E ^c   Mountford, Peter S ^a  

^a MONASH UNIVERSITY   (Australia)

^b BioTransplant Inc   (United States)

^c AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; PRIMATES; SUS SCROFA;

EPITOPE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

CONFERENCE PAPER; GENE DELETION; GENE INSERTION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MONOCYTE; NATURAL KILLER CELL; PRONUCLEUS; PROTEIN MODIFICATION; SWINE; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CLONING, ORGANISM; COMPLEMENT INACTIVATOR PROTEINS; EMBRYO; GENE EXPRESSION; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; NUCLEAR TRANSFER TECHNIQUES; PRIMATES; STEM CELLS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032287056     PISSN: 10313613     EISSN: None     Source Type: Journal    
DOI: 10.1071/rd98112     Document Type: Review

References (111)

1. Alexandre, G.P.J., Gianello, P., Latinne, D., Carlier, M., Dewaele, A., Van Obbergh, L., Moriau, M., Marbaix, E., Lambotte, J.L., Lambotte, L. and Squifflet, J.P. (1989). Plasmapheresis and splenectomy in experimental renal xenotransplantation. In 'Xenografts 25'. (Ed. M.A. Hardy.) pp. 259-66. (Elsevier: New York.)
2. Bach, F.H., Winkler, H., Ferran, C., Hancock, W.W. and Robson, S.C. (1996). Delayed xenograft rejection, Immunol. Today 17, 379-84.
3. Bach, F.H., Ferran, C., Soares, M., Wrighton, C.J., Anrather, J., Winkler, H., Robson, S.C. and Hancock, W.W. (1997a). Modification of vascular responses in xenotransplantation: inflammation and apoptosis. Nature Med. 3, 944-8.
4. Bach, F.H., Ferran, C., Hechenleitner, P., Mark, W., Koyamada, N., Miyatake, T., Winkler, H., Badrichani, A., Candinas, D. and Hancock, W.W. (1997b). Accommodation of vascularized xenografts: expression of 'protective genes' by donor endothelial cells in the host Th2 cytokine environment. Nature Med. 3, 196-204.
5. α gene by DNA microinjected into mouse eggs. Proc. Natl Acad. Sci. USA 86, 7087-91.
6. Calne, R.Y. (1970). Organ transplantation between widely disparate species. Transplant. Proc. 2, 550-3.
7. Campbell, K.H.S., McWhir, J., Ritchie, W.A. and Wilmut, I. (1996). Sheep cloned by nuclear transfer from a cultured cell line. Nature 380, 64-6.
8. Christiansen, D., Milland, J., Thorley, B.R., McKenzie, I.F.C. and Loveland, B.E. (1996). A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro. Eur. J. Immunol. 26, 578-85.
9. Chrupcala, M., Pomer, S., Staehler, G., Waldherr, R. and Kirschfink, C. (1994). Prolongation of discordant renal xenograft survival by depletion of complement: Comparative effects of systemically administered cobra venom factor and soluble complement receptor type 1 in a guinea pig to rat model. Transplant. Int. S650.
10. Cibelli, J.B., Stice, S.L., Golueke, P.J., Kane, J.J., Jerry, J., Blackwell, C., Ponce de Leon, F.A. and Robl, J.M. (1998). Cloned transgenic calves produced from nonquiescent fetal fibroblasts. Science 280, 1256-8.
11. Cooper, D.K.C. (1993). Xenografting: how great is the clinical need. Xeno 1, 25-6.
12. Cooper, D.K.C. (1996). Xenotransplantation - state of the art. Front. Bioscience 1, 248-65.
13. Cooper, D.K.C., Good, A.M., Koren, E., Oriol, R., Malcolm, A.J., Ippolito, R.M., Neethling, F.A., Ye, Y., Romano, E. and Zuhdi, N. (1993a). Identification of α-galactosyl and other carbohydrates that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transplant. Immunol. 1, 198-205.
14. Cooper, D.K.C., Ye, Y., Niekrasz, M., Kehoe, M., Martin, M., Neethling, F.A., Kosanke, S., Debaut, L., Worsley, G., Zuhdi, N., Oriol, R. and Cooper D.K.C. (1993b) Specific intravenous carbohydrate therapy - a new concept in inhibiting antibody-mediated rejection: experience with ABO-incompatible cardiac allografting in the baboon. Transplantation 56, 769-77.
15. Cooper, D.K.C., Koren, E. and Oriol, R. (1994). Oligosaccharides and discordant xenotransplantation Immunol. Rev. 141, 31-58.
16. Cooper, D.K.C., Koren, E. and Oriol, R. (1996). Manipulation of the anti-αGal antibody-αGal epitope system in experimental discordant xenotransplantation. Xenotransplantation 3, 102-111.
17. Cooper, J.T., Stroka, D.M., Brostjan, C., Palmetshofer, A., Bach, F.H. and Ferran C. (1997). A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J. Biol. Chem. 271, 18068-73.
18. Cowan, P.J., Shinkel, T.A., Witort, E.J., Barlow, H., Pearse, M.J and D'Apice, A.J.F. (1996). Targeting gene expression of endothelial cells in transgenic mice using the human intracellular adhesion molecule 2 promoter. Transplantation 62, 155-60.
19. Cozzi, E and White, D.J.G. (1995). The generation of transgenic pigs as potential organ donors for humans Nature Med. 1, 964-6.
20. Cozzi, E., Tucker, A.W., Langford, G.A., Pinochavez, G., Wright, L., Oconnell, M.J., Young, V.J., Lancaster, R., McLaughlin, M., Hunt, K., Bordin, M.C. and White, D.J.G. (1997). Characterization of pigs transgenic for human decay-accelerating factor. Transplantation 64, 1383-92.
21. Dalmasso, A.P., Vercellotti, G.M., Platt, J.L. and Bach, F.H. (1991). Inhibition of complement-mediated endothelial cell cytotoxicity by decay accelerating factor- Potential for prevention of xenograft hyperacute rejection. Transplantation 52, 530-3.
22. Diamond, L.E., McCurry, K.R., Martin, M.J., McClellan, S.B., Oldham, E.R., Platt, J.L. and Logan, J.S. (1996). Characterisation of transgenic pigs expressing functional active human CD59 on cardiac endothelium. Transplantation 61, 1241-9.
23. Esom, C.T. and Fukudome, K. (1995). Cellular regulation of the protein C pathway. Semin. Cell Biol. 6, 259-68.
24. Ferran, C. and Stroka, D. (1997). Adenovirus-mediated gene transfer of A20 renders endothelial cells resistant to activation: a means of evaluating the role of EC activation in xenograft rejection. Transplant. Proc. 29, 879-80.
25. Galili, U. (1993). Interactions of the natural anti-Gal antibody with αgalactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol. Today 14, 480-2.
26. Galili, U., Shohet, S.B., Kobrin, E., Stults, C.L.M. and Macher, B.A. (1988). Man, apes and old world monkeys differ from other mammals in the expression of αgalactosyl epitopes on nucleated cells. J. Biol. Chem. 263, 17755-62.
27. Good, A.H., Cooper, D.K.C., Malcolm, A.J., Ippolito, R.M., Koren, E., Neethling, F.A., Ye, Y., Zuhdi, N. and Lamontagne, L.R. (1992). Identification of carbohydrate structures which bind human anti-porcine antibodies: implications for discordant xenografting in man. Transplant. Proc. 24, 559-62.
28. Gordon, J.W. (1989). Transgenic Animals. Int. Rev. Cytol. 115, 171-229.
29. Grey, S.T. and Hancock, W.W. (1996). A physiological anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes. J. Immunol. 156, 2256-63.
30. Hancock, W.W. and Bach, F.H. (1994). The immunopathology of discordant xenograft rejection. Xeno 2, 68-74.
31. Hancock, W.W. and Bach, F.H. (1997). Immunobiology and therapeutic applications of proteinC/protein S/ thrombomodulin in human and experimental allo- and xenotransplantation. Trends Cardiovasc. Med. 7, 174-83.
32. Hansch, G., Hammer, C.H., Vanguri, P. and Shin, M.L. (1981). Homologous species restriction in lysis of erythrocytes by terminal complement proteins. Proc. Natl Acad. Sci. USA 78, 5118-21.
33. Hechenleitner, P., Mark W., Candinas, D., Miyatake, T., Koyamada, N., Hancock, W.W. and Bach, F.H. (1996). Protective genes expressed in endothelial cells of second hamster heart transplants to rats carrying an accommodated first graft. Xenotransplantation 3, 279-86.
34. Higgins, P.J., Ko, J.L., Lobell, R., Sardonini, C., Alessi, M.K. and Yeh, C.G. (1997). A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor 1 cofactor activities. J. Immunol 158, 2872-81.
35. Hogan, B., Beddington, R., Constantine, F. and Lacy, E. (Editors) (1994). 'Manipulating the mouse embryo - a laboratory manual (2nd Edn).' (Cold Spring Harbour Laboratory Press: Cold Spring Harbor.)
36. Homeister, J.W., Satoh, P.S., Kilgore, K.S. and Lucchesi, B.R. (1993). Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart. J. Immunol. 150, 1055-64.
37. Hourcade, D., Holers, V.M. and Atkinson, J.P. (1989). The regulation of complement activation (RCA) gene cluster. Adv. Immunol. 45, 381-416.
38. Ildstad, S.T. and Sachs, D.H. (1984). Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307, 168-70.
39. Inverardi, L., Clissi, B., Stolzer, A.L., Bender, J.R., Sandrin, M.S. and Pardi, R. (1997). Human natural killer lymphocytes directly recognize evolutionary conserved oligosaccharides ligands expressed by xenogeneic tissues. Transplantation 63, 1313-30.
40. Ish, C., Ong, G.L., Desai, N. and Matters, M.J. (1993). The specificity of alternative complement pathway-mediated lysis of erythrocytes: the survey of complement and target cells from 25 species. Scan. J. Immunol. 38, 113-22.
41. Kaczmarek, E., Koziak, K., Serigny, J., Siegel, J.B., Anrather, J., Beaudoin, A.R., Bach, F.H., and Robson, S.C. (1997). Identification and characterization of CD39 vascular ATP diphosphohydrolase. J. Biol. Chem. 271, 33116-22.
42. Kauffman, H.M., Jr, and Daily, O.P. (1996). Xenotransplamation. The Scientist 10 (4), 11.
43. Kobayashi, T., Taniguchi, S. Ye, Y., Niekrasz, M., Kosanke, S., Neethling, F.A., Wright, L.J., Rose, A.G., White, D.J.G., Hancock, W.W. and Cooper, D.K.C. (1996). Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor. Transplant. Proc. 28, 560.
44. Kopp, C.W., Siegel, J.B., Hancock, W.W., Anrather, J., Winkler, H., Geezt, C.L., Kaczmarek, E., Bach, F.H. and Robson, S.C. (1997). Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. Transplantation 63, 749-58.
45. Koren, E., Milotec, F., Neethling, F.A., Koscec, M., Fei, D., Kobayashi, T., Taniguchi, S., Reichlin, M. and Cooper, D.K.C. (1996). Murine monoclonal anti-idiotypic antibodies directed against human and anti-αGal antibodies prevent rejection of pig cells in culture: implications for pig-to-human organ xenotransplantation. Transplant. Proc. 28, 559.
46. Kozlowski, T., Monroy, R., Xu, Y., Glaser, R., Awwad, M., Cooper, D.K. and Sachs, D.H. (1998a). Anti-Gal(alpha)1-3 antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction. Transplantation 66, 176-82.
47. Kozlowski, T., Ierino, F.L., Lambrigts, D., Foley, A., Andrews, D., Awwad, M., Monroy, R., Cosimi, A.B., Cooper, D.K. and Sachs, D.H. (1998b). Depletion of anti-Gal(alpha)1-3Gal antibody in baboons by specific alpha-Gal immunoaffinity columns. Xenotransplantation 5, 122-31.
48. Kriskos, A., Laherty, C.D. and Dixit, V.M. (1992). Transcriptional activation of theTNFα-inducible zinc finger protein, A20, is mediated by κB elements. J. Biol. Chem. 267, 17971-6.
49. Kroshus, T.J., Dalmasso, A.P., Leventhal, J.R., John, R., Matas, A.J. and Bolman III, R.M. (1995). Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection. J. Surg. Res. 59, 43-50.
50. Lambrigts, D., Van Calster, P., Xu, Y., Awwad, M., Neethling, F.A., Kozlowski, T., Foley, A., Watts, A., Chae, S.J., Fishman, J., Thall, A.D., White-Scharf, M.E., Sachs, D.H. and Cooper, D.K. (1998). Pharmacologic immunosuppressive therapy and extracorporeal immunoadsorption in the suppression of anti-alphaGAl antibody in the baboon. Xenotransplantation 5, 274-83.
51. Lamming, G.E. and Peter, A.R. (1987). Future developments in the manipulation of growth in farm animals. Vet. Rec. 120, 495-9.
52. Land, R.B. and Wilmut, I. (1987). Gene transfer and animal breeding. Theriogeneology 27, 169-79.
53. Langford, G.A., Yannoutsos, N., Cozzi, E., Lancaster, R., Elsome, K., Chen, P., Richards, A. and White D.J. (1994). Production of pigs transgenic for human decay accelerating factor. Transplant. Proc. 26, 1400-1.
54. Lanza, R.P. and Cooper, D.K.C. (1998). Xenotransplantation of cells and tissues. Application to a range of diseases, from diabetes to alzheimers [Review]. Mol. Med. Today 4, 39-45.
55. Lanza, R.P., Cooper, D.K.C. and Chick, W.L. (1997). Xenotransplantation. Sci. Am. 277, 54-9.
56. Lattine, D., Gianello, P., Smith, C.V., Mickeleit, V., Kawai, T., Beadle, M., Haug, C., Sykes, M., Lebowitz, E. and Bazin, H. (1993). Xenotransplantation from pig to cynomolgus monkey: an approach toward tolerance induction. Transplant. Proc. 250, 336-8.
57. Lawson, J.H. and Platt, J.L. (1996). Molecular barriers to xenotransplantation Transplantation 62, 303-10.
58. Leventhal, J.R., Dalmasso, A.P., Cromwell, J.W, Platt, J.L., Manivel, C.J., Bolman III, R.M. and Matas, A.J. (1993). Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 55, 857-65.
59. Leventhal, J.R., Sakiyalak, P., Whitson, J., Simone, P., Matas, A.J., Bolman III, R.M. and Dalmasso, A.P. (1994). Synergistic effect of combined antibody and complement depletion upon discordant cardiac xenograft survival in non human primates. Transplantation 57, 974-8.
60. Li, S., Yeh, J-C., Cooper, D.K.C. and Cummings, R.D. (1995). Inhibition of human anti-αGal IgG by oligosaccharides derived from porcine stomach mucin. Xenotransplantation 2, 279-88.
61. Lin, Y.A., Goebels, J. Xia, G.L. Ji, P. Vandeputte, M. and Waer, M. (1998). Induction of specific transplantation tolerance across xenogeneic barriers in the T-independent immune compartment. Nature Med. 4, 173-80.
62. Liszewski, M.K., Farries, T.C., Lublin, D.M., Rooney, I.A. and Atkinson, J.P. (1996). Control of the complement system [Review]. Adv. Immunol. 61, 201-83.
63. Massey, J.M. (1990). Animal production industry in the year 2000 A.D.. J. Reprod. Fertil. Suppl. 41, 199-208.
64. Matsui, Y., Zsebo, K. And Hogan B.L. (1992). Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 70, 841-7.
65. Medof, M.E., Kinoshita, T. and Nussenzweig, V. (1984). Inhibition of complement activation on the surface of cells after incorporation of decay accelerating factor (DAF) into their membranes. J. Exp. Med. 160, 1558-78.
66. Moran, P., Beasley, H., Gorrell, A., Martin, E., Gribling, P., Fuchs, H., Gillett, N., Burton, L.E. and Caras, I.W. (1992). Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo. J. Immunol. 149, 1736-43.
67. Neethling, F.A., Koren, E., Ye, Y., Richards, S.V., Kujundzic, M., Oriol, R. and Cooper, D.K.C. (1994). Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by α-galactosyl oligosaccharides. Transplantation 57, 959-63.
68. Oriol, R., Ye, Y., Koren, E. and Cooper, D.K.C. (1993). Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 56, 1433-42.
69. Osman, N., McKenzie, I.F.C., Ostenried, K., Ioannou, Y.A., Desncik, R.J. and Sandrin, M.S. (1997). Combined transgenic expression of alpha-galactosidase and alpha-1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Gal-alpha(1,3)Gal. Proc. Natl Acad. Sci. USA 94, 14677-82.
70. Parker, W., Saadi, S., Lin, S.S., Holzknecht, Z.E., Bustos, M. and Platt, J.L. (1996). Transplantation of discordant xenografts: a challenge revisited. Immunol. Today 17, 373-8.
71. Perper, R.J. and Najarian, J.S. (1966). Experimental renal heterotransplantation. I. In widely divergent species. Transplantation 4, 377-88.
72. Piedrahita, J.A., Moore, K., Oetama, B., Chang-kyu, L. Scales, N., Ramsoondar, J., Bazer, F.W. and Ott, T. (1998). Generation of transgenic porcine chimeras using primordial germ cell-derived colonies. Biol. Reprod. 58, 1321-9.
73. Platt, J.L. and Bach, F.H. (1991). Mechanism of tissue injury in hyperacute xenograft rejection. In 'Xenotransplantation (First Edn)'. (Eds D.K.C. Cooper, E. Kemp, K. Reemtsma, and D.J.D. White.) pp. 69-79. (Springer: Heidelberg.)
74. Pruitt, S.K., Baldwin, W.M., Marsh Jr, H.C., Linn, S.S., Yeh, C.G. and Bollinger, R.R. (1991). The effect of soluble human complement receptor type 1 on hyperacute xenograft rejection. Transplantation 52, 868-73.
75. Pruitt, S.K., Kirk, A.D., Bollinger, R.R., Marsh Jr, H.C., Collins, B.H., Levin, J.L., Mault, J.R., Heinle, J.S., Ibrahim, S. and Rudolph. A.R. (1994). The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57, 363-70.
76. Pruitt, S.K., Bollinger, R.R., Collins, B.H., Marsh, H.C., Jr, Levin, J.L., Rudolph, A.R., Baldwin, W.M., III and Sanfilipino, F. (1997). Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. Transplantation 63, 900-2.
77. Pursel, V.G. and Rexroad Jr, C.E. (1993). Status of research with transgenic farm animals. J. Anim. Sci. 71, 10-19.
78. Pursel, V.G., Pinkert, C.A., Miller, K.F., Bolt, D.J., Campbell, R.G. Palmiter, R.D., Brinster, R.L. and Hammer, R.E. (1989). Genetic engineering of livestock. Science 244, 1281-8.
79. Pursel, V.G., Bolt, D.J., Miller, K.F., Pinkert, C.A., Hammer, R.E., Palmiter, R.D. and Brinster, R.L. (1990a). Expression and performance in transgenic pigs. J. Reprod. Fertil. Suppl. 40, 233-45.
80. Pursel, V.G., Hammer, R.E., Bolt, D.J., Palmiter, R.D. and Brinster, R.L. (1990b). Integration, expression and germ-line transmission of growth-related genes in pigs. J. Reprod. Fertil. Suppl. 41, 77-87
81. Roberston, E.J. (1987). Embryo derived stem cells. In 'Teratocarcinomas and embryonic stem cells: a practical approach'. (Ed. E.J. Robertson.) pp. 71-112. (IRL Press: Oxford.)
82. Rose, A.G.. Cooper, D.K.C., Human, P.A., Reichenspurner, H. and Reichart, B. (1991). Histopathology of hyperacute rejection of the heart-experimental and clinical observations in allografts and xenografts. J. Heart Transplant. 10, 223-34.
83. Saadi, S. and Platt, J.L. (1997). Immunology of xenotransplantation [Review]. Life Sci. 62, 365-87.
84. Sablinski, T., Latinne, D., Gianello, P., Bailin, M., Bergen, K., Colvin, R.B., Foley, A., Hong, H-Z., Lorf, T., Meehan, S., Monroy, R., Powelson, J.A., Sykes, M., Tanaka, M. Cosimi, A.B. and Sachs, D.H. (1995). Xenotransplantation of pig kidneys to nonhuman primates: I. Development of a model. Xenotransplantation 2, 264-70.
85. Sachs, D.H., Leight, G. Cone, J., Schwarz, S., Stuart, L. and Rosenberg, S. (1976). Transplantation in miniature swine I. Fixation of the major histocompatability complex. Transplantation 22, 559-67.
86. Sandrin, M.S., Vaughan, H.A. Dabkowski, P.L. and McKenzie, I.F.C. (1993). Anti-pig IgG antibodies in human serum react predominantly with Gal(α1-3)Gal epitopes. Proc. Natl Acad. Sci USA 90, 11391-5.
87. Sandrin, M.S., Fodor, W.L., Mouhtouris, E., Osman, N., Cohney, S., Rollins, S.A., Guilmette, E.R., Setter, E., Squinto, S.P. and McKenzie, I.F.C. (1995). Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Med. 1, 1261-7.
88. Schmoeckel, M., Bhatti, F.N.K., Zaidi, A., Cozzi, E., Pinochavez, G., Dunning, J.J., Wallwork, J. and White D.J.G. (1997). Xenotransplantation of pig organs transgenic for human DAF - an update. Transplant. Proc. 29, 3157-8.
89. Schmoeckel, M., Bhatti, F.N.K., Zaidi, A., Cozzi, E., Waterworth, P.D., Tolan, M.J., Goddard, M., Warner, R.G., Langford, G.A., Dunning, J.J., Wallwork, J. and White D.J.G. (1998). Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 65, 1570-7.
90. Schnieke, A.E., Kind, A.J., Ritchie, W.A., Mycock, K., Scott, A.R., Ritchie, M., Wilmut, I., Colman, A., Campbell, K.H.S. (1997). Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science 278, 2130-3.
91. Seebach, J.D. and Waneck, G.L. (1997). Natural killer cells in xenotransplantation [Review]. Xenotransplanlation 4, 201-11.
92. Schussler, O., Genevaz, D., Latremouille, C., Goussev, N., Kaveri, S. and Glotz, D. (1998). Intravenous immunoglobulins for therapeutic use contain anti-idiotypes against xenophile antibodies and prolong discordant graft survival. Clin. Immunol. Immunopathol. 86, 183-91.
93. Sharabi, Y., Aksentijevich, I., Sundt, T.M., III, Sachs, D.H. and Skyes, M. (1990). Specific tolerance induction across a xenogeneic barrier; production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J. Exp. Med. 172, 195-202.
94. Shinkel, T.A., Chen, C.G., Salvaris, E., Henion, T.R., Barlow, H., Galili, U., Pearse, M.J. and D'Apice A.J.F. (1997). Changes in cell surface glycosylation in alpha-1,3-galactosyltransferase knockout and alpha-1,2-fucosyltransferase transgenic mice. Transplantation 64, 197-204.
95. Siegel, J.B., Grey, S.T., Lesnikoski, B.A., Kopp, C.W., Soares, M., Schute am Exch II, J., Bach F.H., and Robson, S.C. (1997). Xenogeneic endothelial cells activate human prothrombin. Transplantation 64, 888-96.
96. Simon, P.M., Neethling, F.A., Taniguchi, S., Goode, P.L., Zopf, D., Hancock, W.W. and Cooper D.K.C. (1998). Intravenous infusion of Gal-Alpha-1-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Transplantation 65, 346-53.
97. Smitt, J.A. Stark, J.H. and Myburgh, J.A. (1987). Mechanism of immunological tolerance following total lymphoid irradiation. Transplant. Proc. 19, 490-2.
98. Susulic, V.S. Frederich, R.C. Lawitts, J., Tozzo, E., Kahn, B.B., Harper, M-E., Himms-Hage, J., Flier, J.S. and Lowell, B.B. (1995). Targeted disruption of the β3-Adrenergic receptor gene. J. Biol. Chem. 270, 29483-92.
99. Tanaka, M., Latinne, D., Gianello, P., Sablinski, T., Lorf, T., Bailin, M., Nickeleit, V., Colvin, R., Lebowitz, E., Skyes, M., Cosimi, A.B. and Sachs, D.H. (1994). Xenotransplantation from pig to cynomolgus monkey: the potential for overcoming xenograft rejection through induction of chimerism. Transplant. Proc. 26, 1326-7.
100. Taniguchi, S., Neethling, F.A., Korchagina, E.Y., Bovin, N., Ye, Y., Kobayashi, T., Niekrasz, M., Li, S., Koren, E., Oriol, R. and Cooper, D.K. (1996). In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1-3Gal column. Transplantation 62, 1379-84.
101. Tearle, E.R.G., Tange, M.J., Zannettino, Z.L., Katerelos, M., Shinkel, T.A., Van Denderen, B.J.W., Lonie, A.J., Lyons, I., Nottle, M.B., Cox, T., Becker, C., Peura, A.M., Wigley, P.L., Crawford, R.J., Robbins, A.J., Pearse, M.J., and d'Apice, A.J.F. (1996). The α1,3-galactosyltransferase knockout mouse-implications for xenotransplantation. Transplantation 61, 13-19.
102. Thall, A.D., Maly, P. and Lowe, J.B. (1995). Galα1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse J. Biol. Chem. 270, 21437-40.
103. Wagner, T.E. (1985). The role of gene transfer in animal agriculture and biotechnology. Can. J. Anim. Sci. 65, 539-52.
104. Wakayama, T., Perry, A.C.F., Zuccotti, M., Johnson, K.R. and Yanagaimachi, R. (1998). Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 394, 369-74.
105. Weisman, H.F., Bartow, T., Leppo, M.K., Marsh Jr, H.C., Carson, G.R., Concino, M.F., Boyle, M.P., Roux, K.H., Weisfeldt, M.L. and Fearon, D.T. (1990). Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249, 146-51.
106. Wilmut, I., Schnieke, A.E., McWhir, J., Kind, A.J. and Campbell, K.H.S. (1997). Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810-813.
107. Wrighton, C., Kopp, C.W., McShea, A., Vetr, H. and Bach, F.H. (1995). High level of functional human thrombomodulin in cultured porcine aortic endothelial cells. Transplant. Proc. 27, 288-9.
108. Xia, W., Fearon, D.T. and Kirkman, R.L. (1993). Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts. Transplant. Proc. 25, 410-411.
109. Xu, Y., Lorf, T., Sablinski, T., Gianello, P., Bailin, M., Monroy, R., Kozlowski, T., Awwad, M., Cooper, D.K.C. and Sachs, D.H. (1998). Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Gal-Alpha-1-3Gal-Beta-1-4-Beta-Glc-x immunoaffinity column. Transplantation 65, 172-9.
110. Ye, Y., Neethling, F.A. Niekrasz, M., Richards, S.V., Koren, E., Merhav, H., Kosanke, S., Oriol, R. and Cooper, D.K.C. (1994). Evidence that intravenously administered αgalactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 58, 330-7.
111. Zaidi, A., Schmoeckel, M., Bhatti, F., Waterworth, P., Tolan, M., Caozzi, E., Chavez, G., Langford, G.A., Thiru, S., Wallwork, J., White, D. and Friend, P. (1998). Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 65, 1584-90.